Salt intake and non-ACE pathways for intrarenal angiotensin II generation in man

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 2, Issue 1, 2001, Pages 14-18

  Hollenberg, Norman K ^a   Osei, Suzette Y ^a   Lansang, M Cecilia ^a   Price, Deborah A ^a   Fisher, Naomi D L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ACE inhibition; Angiotensin II; Candesartan; Captopril; Renal plasma flow; Renin

Indexed keywords

ANGIOTENSIN II; BENZIMIDAZOLE DERIVATIVE; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TETRAZOLE DERIVATIVE;

ADULT; ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY; KIDNEY CIRCULATION; MALE; METABOLISM; MIDDLE AGED; SODIUM RESTRICTION;

ADULT; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; CAPTOPRIL; DIET, SODIUM-RESTRICTED; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; KIDNEY; MALE; MIDDLE AGED; RENAL CIRCULATION; TETRAZOLES;

EID: 0035295642     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2001.002     Document Type: Article

References (22)

1. Okunishi H, Miyazaki M, Toda N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 1984;2:277-84.
2. Okunishi H, Miyazaki M, Okamura H, Toda N. Different distribution of two types of angiotensin II-generating enzymes in the aortic wall. Biochem Biophys Res Commun 1987;149:1186-92.
3. Okamura T, Okunishi H, Ayajiki K, Toda N. Conversion of angiotensin I to angiotensin II in rabbit aorta. Hypertension 1984;6:216-21.
4. Okunishi H, Oka Y, Shiota N, Kawamoto T, Song K, Miyazaki M. Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents. Jpn J Pharmacol 1993;62:207-10.
5. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II-forming pathways in normal and failing human hearts. Circ Res 1990;66:883-90.
6. Urata H, Kinoshita A, Perez DM et al. Cloning of the gene and cDNA for human heart chymase. J Biol Chem 1991;266: 17173-9.
7. Wolny A, Clozel J-P, Rein J et al. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart. Circ Res 1997;80:219-27.
8. Murakami M, Matsuda H, Kubota E, Wakino S, Honda M, Hayashi K, Saruta T. Role of angiotensin II generated by angiotensin converting enzyme-independent pathways in canine kidney. Kidney Int 1997;52:S132-5.
9. Miura S-I, Ideishi M, Sakai T et al. Angiotensin II formation by an alternative pathway during exercise in humans. J Hypertens 1994;12:1177-81.
10. Hollenberg NK, Fisher NDL, Price DA. Pathways for angiotensin II generation in intact human tissue. Evidence from comparative pharmacological interruption of the renin system. Hypertension 1998;32:387-92.
11. Osei SY, Price DA, Fisher NDL, Porter LE, Laffel LMB, Hollenberg NK. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans. Hypertension 1999;3:559-64.
12. Price DA, Fisher NDL, Williams GH, Hollenberg NK. Renal perfusion is reduced in healthy blacks. JASN abstract #1756, 1998;9:345.
13. Lansang MC, Osei SY, Price DA, Fisher NDL, Hollenberg NK. Renal hemodynamic and hormonal responses to angiotensin II antagonist candesartan. Hypertension 2000;36:834-8.
14. Emanuel RL, Cain JP, Williams GH. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med 1973;81:632-40.
15. Krulewitz AH, Fanburg BL. Stimulation of bovine endothelial cell angiotensin I converting enzyme activity by cyclic AMP-related agents. J Cell Physiol 1986;129:147-50.
16. Forslund T, Tikkanen I, Gronhagen-Riska C, Fyhrquist F. Dissociation of the effect of captopril on blood pressure and angiotensin converting enzyme in serum and lungs of spontaneously hypertensive rats. Acta Pharmacol Toxicol 1981;49:416-21.
17. Fyhrquist F, Gronhagen-Riska C, Hortling L, Forslund T, Tikkanen I, Klockars M. The induction of angiotensin converting enzyme by its inhibitors. Clin Exp Hypertens [A] 1983;5:1319-30.
18. Schunkert H, Ingelfinger JR, Hirsch AT et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993;72:312-8.
19. Vos PF, Boer P, Braam B, Koomans HA. Efficacy of intrarenal ACE inhibition estimated from the renal response to angiotensin I and II in humans. Kidney Int 1995;47:274-81.
20. Krekels MME, Spiering W, Schaper NC, Houben AJHM, de Leeuw PW. Dissociation between the renal effects of angiotensin I and II in sodium-restricted normal subjects. Cardiovasc Res 1998;38:215-20.
21. Hollenberg NK, Fisher NDL, Price DA, Williams GH. Effect of ACE inhibition on pressor, renal vascular, and adrenal responses to infusion of angiotensin I in normal subjects eating a low-salt diet. AJH 2000;13:498-503.
22. Lansang MC, Hollenberg NK. ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response. JRAAS 2000;1:119-24.